Maria C Bennell1, Feng Qiu1, Kori J Kingsbury1, Peter C Austin1, Harindra C Wijeysundera2. 1. Schulich Heart Centre (Bennell, Wijeysundera), Division of Cardiology, Sunnybrook Health Sciences Centre, University of Toronto; the Institute of Health Policy, Management and Evaluation (Austin, Wijeysundera), University of Toronto; the Institute for Clinical Evaluative Sciences (Qiu, Austin, Wijeysundera); the Cardiac Care Network of Ontario (Kingsbury), Toronto, Ont. 2. Schulich Heart Centre (Bennell, Wijeysundera), Division of Cardiology, Sunnybrook Health Sciences Centre, University of Toronto; the Institute of Health Policy, Management and Evaluation (Austin, Wijeysundera), University of Toronto; the Institute for Clinical Evaluative Sciences (Qiu, Austin, Wijeysundera); the Cardiac Care Network of Ontario (Kingsbury), Toronto, Ont. harindra.wijeysundera@sunnybrook.ca.
Abstract
BACKGROUND: The ratio of revascularization to medical therapy (referred to herein as the revascularization ratio) for the initial treatment of stable ischemic heart disease varies considerably across hospitals. We conducted a comprehensive study to identify patient, physician and hospital factors associated with variations in the revascularization ratio across 18 cardiac centres in the province of Ontario. We also explored whether clinical outcomes differed between hospitals with high, medium and low ratios. METHODS: We identified all patients in Ontario who had stable ischemic heart disease documented by index angiography performed between Oct. 1, 2008, and Sept. 30, 2011, at any of the 18 cardiac centres in the province. We classified patients by initial treatment strategy (medical therapy or revascularization). Hospitals were classified into equal tertiles based on their revascularization ratio. The primary outcome was all-cause mortality. Patient follow-up was until Dec. 31, 2012. Hierarchical logistic regression models identified predictors of revascularization. Multivariable Cox proportional hazards models, with a time-varying covariate for actual treatment received, were used to evaluate the impact of the revascularization ratio on clinical outcomes. RESULTS: Variation in revascularization ratios was twofold across the hospitals. Patient factors accounted for 67.4% of the variation in revascularization ratios. Physician and hospital factors were not significantly associated with the variation. Significant patient-level predictors of revascularization were history of smoking, multivessel disease, high-risk findings on noninvasive stress testing and more severe symptoms of angina (v. no symptoms). Treatment at hospitals with a high revascularization ratio was associated with increased mortality compared with treatment at hospitals with a low ratio (hazard ratio 1.12, 95% confidence interval 1.03-1.21). INTERPRETATION: Most of the variation in revascularization ratios across hospitals was warranted, in that it was driven by patient factors. Nonetheless, the variation was associated with potentially important differences in mortality.
BACKGROUND: The ratio of revascularization to medical therapy (referred to herein as the revascularization ratio) for the initial treatment of stable ischemic heart disease varies considerably across hospitals. We conducted a comprehensive study to identify patient, physician and hospital factors associated with variations in the revascularization ratio across 18 cardiac centres in the province of Ontario. We also explored whether clinical outcomes differed between hospitals with high, medium and low ratios. METHODS: We identified all patients in Ontario who had stable ischemic heart disease documented by index angiography performed between Oct. 1, 2008, and Sept. 30, 2011, at any of the 18 cardiac centres in the province. We classified patients by initial treatment strategy (medical therapy or revascularization). Hospitals were classified into equal tertiles based on their revascularization ratio. The primary outcome was all-cause mortality. Patient follow-up was until Dec. 31, 2012. Hierarchical logistic regression models identified predictors of revascularization. Multivariable Cox proportional hazards models, with a time-varying covariate for actual treatment received, were used to evaluate the impact of the revascularization ratio on clinical outcomes. RESULTS: Variation in revascularization ratios was twofold across the hospitals. Patient factors accounted for 67.4% of the variation in revascularization ratios. Physician and hospital factors were not significantly associated with the variation. Significant patient-level predictors of revascularization were history of smoking, multivessel disease, high-risk findings on noninvasive stress testing and more severe symptoms of angina (v. no symptoms). Treatment at hospitals with a high revascularization ratio was associated with increased mortality compared with treatment at hospitals with a low ratio (hazard ratio 1.12, 95% confidence interval 1.03-1.21). INTERPRETATION: Most of the variation in revascularization ratios across hospitals was warranted, in that it was driven by patient factors. Nonetheless, the variation was associated with potentially important differences in mortality.
Authors: Yana Gurevich; Anne McFarlane; Kathleen Morris; Aleksandra Jokovic; Gail M Peterson; Gregory K Webster Journal: Can J Cardiol Date: 2010 Aug-Sep Impact factor: 5.223
Authors: Jack V Tu; Dennis T Ko; Helen Guo; Janice A Richards; Nancy Walton; Madhu K Natarajan; Harindra C Wijeysundera; Derek So; David A Latter; Christopher M Feindel; Kori Kingsbury; Eric A Cohen Journal: CMAJ Date: 2011-12-12 Impact factor: 8.262
Authors: Jaskaran S Kang; Maria C Bennell; Feng Qiu; Merril L Knudtson; Peter C Austin; Dennis T Ko; Harindra C Wijeysundera Journal: CMAJ Open Date: 2016-08-08
Authors: Gabby Elbaz-Greener; Feng Qiu; John G Webb; Kayley A Henning; Dennis T Ko; Andrew Czarnecki; Idan Roifman; Peter C Austin; Harindra C Wijeysundera Journal: J Am Heart Assoc Date: 2019-06-05 Impact factor: 5.501
Authors: Elizabeth L Nichols; Glyn Elwyn; Anthony DiScipio; Mandeep S Sidhu; A James O'Malley; Daniel D Matlock; Shama Alam; Cathy S Ross; Megan Coylewright; David J Malenka; Jeremiah R Brown Journal: BMC Cardiovasc Disord Date: 2021-08-27 Impact factor: 2.298
Authors: Amneet Sandhu; Maggie A Stanislawski; Gary K Grunwald; Kathryn Guinn; Javier Valle; Daniel Matlock; P Michael Ho; Thomas M Maddox; Steven M Bradley Journal: J Am Heart Assoc Date: 2017-09-12 Impact factor: 5.501
Authors: Rafael N Miranda; Feng Qiu; Ragavie Manoragavan; Stephen Fremes; Sandra Lauck; Louise Sun; Christopher Tarola; Derrick Y Tam; Mamas Mamas; Harindra C Wijeysundera Journal: Open Heart Date: 2022-01